Search research articles
Contact Us
Filters
Showing results (1-10 of 45) with videos related to
Page
of 5
Sort By:
Infection Control and Hospital Epidemiology
|
February 20, 2015
Is procalcitonin-guided antimicrobial use cost-effective in adult patients with suspected bacterial infection and sepsis?
Michelle Harrison, Curtis D Collins
Pharmacotherapy
|
January 7, 2014
Comparative cost-effectiveness of alternative empiric antimicrobial treatment options for suspected enterococcal bacteremia
Meghan N McComb, Curtis D Collins
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 23, 2015
Linezolid Versus Vancomycin in the Empiric Treatment of Nosocomial Pneumonia: A Cost-Utility Analysis Incorporating Results from the ZEPHyR Trial
Curtis D Collins, Ann K Schwemm
Hospital Pharmacy
|
November 4, 2021
Antimicrobial Stewardship by Transitions of Care Pharmacists at Hospital Discharge
Noah Leja, Curtis D Collins, Janice Duker
Patient Preference and Adherence
|
August 17, 2011
Management of oropharyngeal candidiasis with localized oral miconazole therapy: efficacy, safety, and patient acceptability
Curtis D Collins, Sarah Cookinham, Jeannina Smith
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
July 19, 2021
Open-source institutional guideline recommendations during the COVID-19 pandemic
Curtis D Collins, Jean Huang, Brian A Potoski
Pharmacotherapy
|
June 28, 2005
Azithromycin-warfarin interaction: are we fishing with a red herring?
Gregory Eschenauer, Curtis D Collins, Randolph E Regal
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 30, 2013
Cost-effectiveness analysis evaluating fidaxomicin versus oral vancomycin for the treatment of Clostridium difficile infection in the United States
Paul M Stranges, David W Hutton, Curtis D Collins
Current Pharmaceutical Design
|
August 12, 2008
New developments in antimicrobial use in sepsis
Daniel R Kaul, Curtis D Collins, Robert C Hyzy
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 21, 2008
Comparative cost-effectiveness of posaconazole versus fluconazole or itraconazole prophylaxis in patients with prolonged neutropenia
Curtis D Collins, Jeffrey J Ellis, Daniel R Kaul
Page
of 5
Search research articles
Search
Showing results (1-10 of 45) with videos related to
Sort By:
Page
of 5
Infection Control and Hospital Epidemiology
|
February 20, 2015
Is procalcitonin-guided antimicrobial use cost-effective in adult patients with suspected bacterial infection and sepsis?
Michelle Harrison, Curtis D Collins
Pharmacotherapy
|
January 7, 2014
Comparative cost-effectiveness of alternative empiric antimicrobial treatment options for suspected enterococcal bacteremia
Meghan N McComb, Curtis D Collins
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 23, 2015
Linezolid Versus Vancomycin in the Empiric Treatment of Nosocomial Pneumonia: A Cost-Utility Analysis Incorporating Results from the ZEPHyR Trial
Curtis D Collins, Ann K Schwemm
Hospital Pharmacy
|
November 4, 2021
Antimicrobial Stewardship by Transitions of Care Pharmacists at Hospital Discharge
Noah Leja, Curtis D Collins, Janice Duker
Patient Preference and Adherence
|
August 17, 2011
Management of oropharyngeal candidiasis with localized oral miconazole therapy: efficacy, safety, and patient acceptability
Curtis D Collins, Sarah Cookinham, Jeannina Smith
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
July 19, 2021
Open-source institutional guideline recommendations during the COVID-19 pandemic
Curtis D Collins, Jean Huang, Brian A Potoski
Pharmacotherapy
|
June 28, 2005
Azithromycin-warfarin interaction: are we fishing with a red herring?
Gregory Eschenauer, Curtis D Collins, Randolph E Regal
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 30, 2013
Cost-effectiveness analysis evaluating fidaxomicin versus oral vancomycin for the treatment of Clostridium difficile infection in the United States
Paul M Stranges, David W Hutton, Curtis D Collins
Current Pharmaceutical Design
|
August 12, 2008
New developments in antimicrobial use in sepsis
Daniel R Kaul, Curtis D Collins, Robert C Hyzy
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 21, 2008
Comparative cost-effectiveness of posaconazole versus fluconazole or itraconazole prophylaxis in patients with prolonged neutropenia
Curtis D Collins, Jeffrey J Ellis, Daniel R Kaul
Page
of 5